Tradename | Company | Number | Date | Products |
---|---|---|---|---|
DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | Baxter | N-213645 RX | 2023-02-27 | 4 products, RLD, RS |
DAPTOMYCIN | Hospira | N-210282 RX | 2021-06-21 | 2 products, RLD, RS |
DAPTOMYCIN | Sagent Pharmaceuticals | N-208385 RX | 2017-09-12 | 1 products, RLD, RS |
DAPTOMYCIN | Xellia | N-209949 RX | 2017-10-20 | 1 products, RLD, RS |
DAPTOMYCIN | Xellia | N-217415 RX | 2023-01-30 | 2 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
cubicin | New Drug Application | 2023-08-24 |
cubicin rf | New Drug Application | 2023-08-14 |
daptomycin | ANDA | 2024-01-19 |
daptomycin in sodium chloride | New Drug Application | 2023-02-27 |
dapzura rt | New Drug Application | 2022-01-25 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
bacteremia | EFO_0003033 | D016470 | R78.81 |
bacterial infections | — | D001424 | A49 |
bacterial skin diseases | — | D017192 | — |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Daptomycin, Daptomycin In 0.9% Sodium Chloride, Baxter Hlthcare Corp | |||
11173189 | 2041-03-11 | DP | U-3294 |
Daptomycin, Daptomycin, Xellia Pharms Aps | |||
11759497 | 2038-08-28 | DP | |
Daptomycin, Daptomycin, Hospira | |||
9655946 | 2033-09-11 | DP | U-3175 |
10357535 | 2033-09-11 | DP | U-3176 |
Daptomycin, Cubicin, Cubist Pharms Llc | |||
9138456 | 2030-11-23 | DP | |
8003673 | 2028-09-04 | U-1180 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Bacteremia | D016470 | EFO_0003033 | R78.81 | — | 6 | 4 | 9 | 2 | 21 |
Endocarditis | D004696 | HP_0100584 | — | — | 1 | — | 3 | 2 | 6 |
Staphylococcal infections | D013203 | — | A49.01 | — | 1 | 2 | 3 | — | 6 |
Sepsis | D018805 | HP_0100806 | A41.9 | 1 | 1 | — | 1 | 2 | 5 |
Soft tissue infections | D018461 | — | — | — | 2 | 1 | 1 | 1 | 5 |
Osteomyelitis | D010019 | EFO_0003102 | M86 | — | 2 | — | 2 | — | 4 |
Renal insufficiency | D051437 | HP_0000083 | N19 | 1 | — | 1 | 1 | 1 | 4 |
Infectious skin diseases | D012874 | — | — | — | 1 | 1 | 1 | — | 3 |
Cellulitis | D002481 | EFO_0003035 | L03.90 | — | — | — | 3 | — | 3 |
Bacterial endocarditis | D004697 | EFO_1000830 | — | — | 1 | 1 | 1 | — | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Infections | D007239 | EFO_0000544 | — | — | 1 | 2 | — | 4 | 7 |
Gram-positive bacterial infections | D016908 | — | — | 2 | 1 | 1 | — | 2 | 6 |
Bacterial pneumonia | D018410 | EFO_1001272 | J15.9 | — | — | 2 | — | — | 2 |
Surgical wound infection | D013530 | — | — | — | — | 1 | — | 1 | 2 |
Staphylococcus aureus | D013211 | NCBITaxon_1280 | — | — | 1 | 1 | — | — | 2 |
Critical care | D003422 | — | — | — | — | 1 | — | — | 1 |
Gram-positive bacteria | D006094 | — | — | — | — | 1 | — | — | 1 |
Cross infection | D003428 | — | — | — | — | 1 | — | — | 1 |
Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | 1 | 1 | — | — | 1 |
Ascites | D001201 | HP_0001541 | R18 | — | 1 | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Bacterial infections | D001424 | — | A49 | — | 1 | — | — | 1 | 2 |
Neutropenia | D009503 | — | D70 | — | 1 | — | — | 1 | 2 |
Neoplasms | D009369 | — | C80 | — | 1 | — | — | 1 | 2 |
Pneumococcal meningitis | D008586 | EFO_1001114 | G00.1 | — | 1 | — | — | — | 1 |
Fever | D005334 | HP_0001945 | R50.9 | — | 1 | — | — | — | 1 |
Hot flashes | D019584 | — | — | — | 1 | — | — | — | 1 |
Sweating | D013546 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Meningitis | D008581 | HP_0001287 | G03 | 1 | — | — | — | 1 | 2 |
Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | 2 | — | — | — | — | 2 |
Subcutaneous injections | D007279 | — | — | 1 | — | — | — | — | 1 |
Pharmacokinetics | D010599 | — | — | 1 | — | — | — | — | 1 |
Drug interactions | D004347 | — | — | 1 | — | — | — | — | 1 |
Healthy volunteers/patients | — | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Drug-related side effects and adverse reactions | D064420 | — | T88.7 | — | — | — | — | 2 | 2 |
Acute kidney injury | D058186 | HP_0001919 | N17 | — | — | — | — | 2 | 2 |
Inappropriate prescribing | D057970 | — | — | — | — | — | — | 1 | 1 |
Fatal outcome | D017809 | — | — | — | — | — | — | 1 | 1 |
Cerebral hemorrhage | D002543 | — | — | — | — | — | — | 1 | 1 |
Subarachnoid hemorrhage | D013345 | EFO_0000713 | I60 | — | — | — | — | 1 | 1 |
Drug monitoring | D016903 | — | — | — | — | — | — | 1 | 1 |
Hemodiafiltration | D017583 | — | — | — | — | — | — | 1 | 1 |
Mediastinitis | D008480 | — | J98.51 | — | — | — | — | 1 | 1 |
Heart-assist devices | D006353 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Daptomycin |
INN | daptomycin |
Description | Daptomycin, sold under the brand name Cubicin among others, is a lipopeptide antibiotic used in the treatment of systemic and life-threatening infections caused by Gram-positive organisms.
|
Classification | Small molecule |
Drug class | aptamers, classical and mirror; antibiotics (Streptomyces strain) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C |
PDB | — |
CAS-ID | 103060-53-3 |
RxCUI | — |
ChEMBL ID | CHEMBL387675 |
ChEBI ID | 600103 |
PubChem CID | 16129629 |
DrugBank | DB00080 |
UNII ID | NWQ5N31VKK (ChemIDplus, GSRS) |